Related Experiment Video
Updated: Oct 2, 2026

High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence
Published on: February 23, 2021
[Clinical evaluation of ofloxacin against complicated urinary tract infections]
1Department of Urology, Seichokai Fuchu Hospital.
Abstract:
Clinical efficacy of ofloxacin (OFLX) against complicated urinary tract infections was examined in 20 patients. OFLX was administrated orally at a dose of 200 mg, three times (daily 600 mg) for 14 to 102 days. The overall clinical efficacy was rated excellent in 8 cases (40%), moderate in 7 cases (35%) and poor in 5 cases (25%) with a total efficacy of 75%. Bacteriological efficacy, 17 out of 24 strains (70.8%) isolated were eradicated after OFLX administration. The strains that appeared after OFLX treatment were P. cepacia and Candida sp. No severe side effects were found in these patients.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Urine Studies II: Urine Culture and Sensitivity Test
Inhibitors of Bacterial DNA Synthesis

